Yi-Wei Lin Selected Research

Yi-Wei Lin Research Topics

Disease

8	Neoplasms (Cancer) 06/2023 - 11/2010
7	Inflammation (Inflammations) 01/2023 - 02/2015
5	Prostatic Neoplasms (Prostate Cancer) 06/2023 - 01/2012
4	Obesity 01/2020 - 09/2017
3	Esophageal Squamous Cell Carcinoma 11/2023 - 01/2021
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013 - 11/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 06/2023
2	Hypertrophy 01/2020 - 11/2019
2	Carcinogenesis 07/2013 - 01/2013
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Adenocarcinoma 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Glucose Intolerance 01/2020
1	Heart Failure 09/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2019
1	Fibrosarcoma 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Bone Diseases (Bone Disease) 01/2017
1	Metabolic Diseases (Metabolic Disease) 12/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Insulin Resistance 04/2015
1	Atherosclerosis 02/2015
1	Atherosclerotic Plaque (Atheroma) 02/2015
1	Neoplasm Metastasis (Metastasis) 11/2014
1	Complementation Group D Xeroderma Pigmentosum 07/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Fibrosis (Cirrhosis) 06/2011
1	Leukemia 01/2009
1	Severe Acute Respiratory Syndrome 12/2004

Drug/Important Bio-Agent (IBA)

7	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 01/2009
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2015
4	Carrier Proteins (Binding Protein)IBA 01/2021 - 09/2019
3	Insulin-Like PeptidesIBA 01/2024 - 01/2012
3	Insulin-Like Growth Factor Binding Protein 1IBA 01/2024 - 01/2021
3	ORALIT (ORS)IBA 06/2023 - 01/2013
2	AutoantibodiesIBA 01/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 12/2016 - 12/2004
2	TeaIBA 01/2013 - 01/2013
1	Messenger RNA (mRNA)IBA 01/2024
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Complement Factor B (Factor B)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Alkaline PhosphataseIBA 01/2023
1	AlbuminsIBA 01/2023
1	Complement C3 (C3 Complement)IBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	AntigensIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	EnzymesIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Mitogen-Activated Protein Kinase 3IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	raf KinasesIBA 01/2019
1	CateninsIBA 01/2018
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2018
1	Dietary Fats (Dietary Fat)IBA 09/2017
1	Nuclear Receptor Interacting Protein 1IBA 01/2017
1	Dietary Fiber FDA Link 01/2017
1	Apolipoproteins E (ApoE)IBA 02/2015
1	CholesterolIBA 02/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2015
1	oxidized low density lipoproteinIBA 02/2015
1	LuciferasesIBA 11/2014
1	DNA Glycosylases (DNA Glycosylase)IBA 07/2013
1	8-hydroxyguanineIBA 07/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	glutathione S-transferase M1IBA 01/2013
1	Liposomes (Liposome)IBA 01/2012
1	honokiolIBA 06/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2010
1	ResveratrolIBA 11/2010
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 01/2009

Therapy/Procedure

4	Therapeutics 01/2020 - 11/2010
2	Neoadjuvant Therapy 11/2023 - 01/2022
1	Castration 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2015
1	Activator Appliances (Function Activator) 01/2009